Aijaz Ahmed, MD

Articles by Aijaz Ahmed, MD

Treating Medicaid Patients With Hepatitis C: Clinical and Economic Impact

ByZobair Younossi, MD,Stuart C. Gordon, MD,Aijaz Ahmed, MD,Douglas Dieterich, MD,Sammy Saab, MD,Rachel Beckerman, PhD

February 16th 2017

Hepatitis C virus treatment is often restricted in Medicaid patients. This analysis evaluates the clinical and cost impacts of treating all Medicaid patients versus the current status quo.

Real-World Outcomes of Ledipasvir/Sofosbuvir in Treatment-Naïve Patients With Hepatitis C

ByZobair M. Younossi, MD, MPH, FACG, AGAF, FAASLD,Haesuk Park, PhD,Stuart C. Gordon, MD,John R. Ferguson,Aijaz Ahmed, MD,Douglas Dieterich, MD,Sammy Saab, MD, MPH

May 3rd 2016

In the treatment of hepatitis C virus, the gap between efficacy and real-world effectiveness narrows with improved tolerability and ease of use.

Latest Updated Articles

Real-World Outcomes of Ledipasvir/Sofosbuvir in Treatment-Naïve Patients With Hepatitis C
May 3rd 2016
Treating Medicaid Patients With Hepatitis C: Clinical and Economic Impact
February 16th 2017

Aijaz Ahmed, MD

Articles by Aijaz Ahmed, MD

Treating Medicaid Patients With Hepatitis C: Clinical and Economic Impact

Real-World Outcomes of Ledipasvir/Sofosbuvir in Treatment-Naïve Patients With Hepatitis C

Latest Updated Articles

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%

Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies